https://www.selleckchem.com/products/amg510.html
4 vs. 5.2%, P less then 0.01) were found for the nPA group than for the hPA group, respectively. Logistic regression analysis identified baseline PAC as a significant independent predictor of absent clinical success of ADX and MRAs. Conclusions Plasma aldosterone concentration at baseline was a significant and independent predictor of absent clinical success of ADX and MRA. Mineralocorticoid receptor antagonist treatment appeared to be a better therapeutic choice than ADX in the nPA group. © Endocrine Society 2020.We have previously repo
Respect!
Kommentar
Delen
